Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Jounce Therapeutics Inc.

    NASDAQ: JNCE · Real-Time Price · USD
    1.88
    0.00 (0.00%)
    At close: May 03, 2023, 10:00 PM

    Jounce Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -50.92M -90.87M
    Depreciation & Amortization
    		 2.09M 2.83M
    Stock-Based Compensation
    		 10.27M 11.48M
    Other Working Capital
    		 8.46M -7.52M
    Other Non-Cash Items
    		 800K 921K
    Deferred Income Tax
    		 n/a n/a
    Change in Working Capital
    		 8.88M -7.85M
    Operating Cash Flow
    		 -28.88M -83.49M
    Capital Expenditures
    		 -919K -373K
    Cash Acquisitions
    		 n/a n/a
    Purchase of Investments
    		 -24.93M -130.27M
    Sales Maturities Of Investments
    		 109.33M 70.13M
    Other Investing Acitivies
    		 n/a n/a
    Investing Cash Flow
    		 83.48M -60.51M
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 n/a n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 442K 92.04M
    Financial Cash Flow
    		 442K 92.04M
    Net Cash Flow
    		 55.04M -51.96M
    Free Cash Flow
    		 -29.8M -83.87M

    Add to Watchlist